David Meline

CFO

Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Moderna, Inc. (MRNA)	Former Chief Financial Officer	$426,497	$428,055	$1,918,342	$1,918,533	—	$76,718	$4,768,145
2021	Moderna, Inc. (MRNA)	Former Chief Financial Officer	$616,962	—	$2,000,000	$2,000,000	$560,000	$59,312	$5,236,274
2020	Moderna, Inc. (MRNA)	Former Chief Financial Officer	$334,616	$339,344	—	$8,600,000	—	—	$9,273,960

Executive changes

Resigned member of the Board at Pacific Biosciences Of California, Inc. (PACB)
2025-01-30
Appointed Class II Director at Pacific Biosciences Of California, Inc. (PACB)
2024-06-20
Appointed Class II director at Pacific Biosciences Of California, Inc. (PACB)
2023-10-13
Retired Chief Financial Officer at Moderna, Inc. (MRNA)
2022-09-06
Retired Chief Financial Officer at Moderna, Inc. (MRNA)
2022-07-08

Earnings-call appearances

Moderna Q2 Earnings call
Moderna, Inc. (MRNA)

2026-07-31
Moderna, Inc. Q2 FY2022 Earnings Call
Moderna, Inc. (MRNA)

2022-08-03
Moderna, Inc. Q1 FY2022 Earnings Call
Moderna, Inc. (MRNA)

2022-05-04
Moderna, Inc. Q4 FY2021 Earnings Call
Moderna, Inc. (MRNA)

2022-02-24
Moderna, Inc. Q3 FY2021 Earnings Call
Moderna, Inc. (MRNA)

2021-11-04
Moderna, Inc. Q2 FY2021 Earnings Call
Moderna, Inc. (MRNA)

2021-08-05
Moderna, Inc. Q1 FY2021 Earnings Call
Moderna, Inc. (MRNA)

2021-05-06
Moderna, Inc. Q4 FY2020 Earnings Call
Moderna, Inc. (MRNA)

2021-02-25
Moderna, Inc. Q3 FY2020 Earnings Call
Moderna, Inc. (MRNA)

2020-10-29
Moderna, Inc. Q2 FY2020 Earnings Call
Moderna, Inc. (MRNA)

2020-08-05